| RXi Pharmaceuticals Corp. announced that Noah D. Beerman has joined the company as its new President and CEO. The appointment of Mr. Beerman as CEO is part of a planned succession in leadership as the company looks to advance from the research stage to product development and execution of therapeutic collaborations and partnerships. He succeeds RXi’s co-founder, Tod Woolf, Ph.D., who will continue as a member of RXi’s Scientific Advisory Board. :theflyonthewall.com |
